Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Strategic Education
STRA
$1.78B
| $20.8M | ﹤0.01% |
259,422
-20,463
| -7% | -$1.63M |
|
2902
iShares BB Rated Corporate Bond ETF
HYBB
$410M
| $20.7M | ﹤0.01% |
439,046
-106,210
| -19% | -$5M |
|
2903
First Trust Emerging Markets Small Cap AlphaDEX Fund
FEMS
$244M
| $20.7M | ﹤0.01% |
491,391
-34,747
| -7% | -$1.48M |
|
2904
iShares High Yield Systematic Bond ETF
HYDB
$1.61B
| $20.7M | ﹤0.01% |
436,471
-19,173
| -4% | -$908K |
|
2905
Sundial Growers
SNDL
$351M
| $20.6M | ﹤0.01% |
12,417,045
+70,907
| +0.6% | +$142K |
|
2906
JPMorgan Diversified Return International Equity ETF
JPIN
$363M
| $20.5M | ﹤0.01% |
301,199
-3,713
| -1% | -$251K |
|
2907
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.32B
| $20.5M | ﹤0.01% |
454,665
+9,344
| +2% | +$425K |
|
2908
York Water
YORW
$502M
| $20.5M | ﹤0.01% |
642,716
+459,067
| +250% | +$14.7M |
|
|
ARR
2909
Armour Residential REIT
ARR
$2.01B
| $20.4M | ﹤0.01% |
1,155,245
+97,544
| +9% | +$1.62M |
|
|
RIV
2910
RiverNorth Opportunities Fund
RIV
$308M
| $20.3M | ﹤0.01% |
1,732,561
-48,649
| -3% | -$567K |
|
|
FNGU
2911
MicroSectors FANG+ 3x Leveraged ETNs due Feb 17 2045
FNGU
$2.02B
| $20.3M | ﹤0.01% |
804,852
+793,052
| +6,721% | +$22.9M |
|
2912
FlexShares Quality Dividend Index Fund
QDF
$2.22B
| $20.3M | ﹤0.01% |
251,322
+861
| +0.3% | +$69K |
|
2913
American Superconductor
AMSC
$1.48B
| $20.3M | ﹤0.01% |
705,442
+369,677
| +110% | +$16M |
|
2914
iShares S&P GSCI Commodity-Indexed Trust
GSG
$981M
| $20.3M | ﹤0.01% |
879,534
+10,931
| +1% | +$252K |
|
|
PCI
2915
PGIM Corporate Bond 5-10 Year ETF
PCI
$529M
| $20.3M | ﹤0.01% |
400,000
| – | – |
|
2916
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$751M
| $20.3M | ﹤0.01% |
635,983
-7,323
| -1% | -$228K |
|
2917
Beam Therapeutics
BEAM
$2.58B
| $20.2M | ﹤0.01% |
729,400
+84,640
| +13% | +$2.16M |
|
2918
Cohen & Steers Real Estate Opportunities and Income Fund
RLTY
$271M
| $20.2M | ﹤0.01% |
1,373,956
+25,726
| +2% | +$384K |
|
2919
SGHC Ltd
SGHC
$7.45B
| $20.2M | ﹤0.01% |
1,689,985
+525,434
| +45% | +$6.32M |
|
|
NPKI
2920
NPK International
NPKI
$1.19B
| $20.2M | ﹤0.01% |
1,693,062
+50,157
| +3% | +$612K |
|
2921
Blue Bird Corp
BLBD
$2.41B
| $20.1M | ﹤0.01% |
428,634
+144,395
| +51% | +$7.55M |
|
2922
Denali Therapeutics
DNLI
$3.74B
| $20.1M | ﹤0.01% |
1,219,854
-469,638
| -28% | -$7.93M |
|
2923
Kemper
KMPR
$1.73B
| $20.1M | ﹤0.01% |
496,492
+194,206
| +64% | +$8.32M |
|
|
PPTA
2924
Perpetua Resources
PPTA
$2.28B
| $20.1M | ﹤0.01% |
831,081
+80,791
| +11% | +$1.99M |
|
2925
BigBear.ai
BBAI
$1.36B
| $20.1M | ﹤0.01% |
3,718,024
+956,901
| +35% | +$6.25M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.